As of 4:02pm ET
| -1.30 / -2.42%|
The 7 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 55.00, with a high estimate of 60.00 and a low estimate of 49.00. The median estimate represents a +5.10% increase from the last price of 52.33.
The current consensus among 7 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.